Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 2011 | 2020 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.400 | None | 1.000 | 15 | 0 | 1997 | 2019 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
phenotype | 0.100 | None | 0.929 | 14 | 0 | 1993 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.150 | None | 1.000 | 5 | 0 | 1996 | 2017 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1993 | 2018 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2015 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 1991 | 2018 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2016 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.130 | None | 1.000 | 3 | 0 | 1990 | 2017 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2015 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
phenotype | 0.320 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2018 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
phenotype | 0.020 | None | 0.500 | 2 | 0 | 2001 | 2008 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.030 | None | 1.000 | 2 | 0 | 1991 | 2011 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2018 | ||||||||
|
integrin subunit beta 2 | 0.444 | 0.923 | 5.1E-15 |
|
phenotype | 0.120 | None | 1.000 | 2 | 0 | 2001 | 2001 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
leucyl and cystinyl aminopeptidase | 0.514 | 0.731 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2011 |